34 research outputs found

    Automatic CAD-model Repair: Shell-Closure

    Get PDF
    Shell-closure is critical to the repair of CAD-models described in the .STL file-format, the de facto solid freeform fabrication industry-standard. Polyhedral CAD-models that do not exhibit shell-closure, i.e. have cracks, holes, or gaps, do not constitute valid solids and frequently cause problems during fabrication. This paper describes a solution for achieving shell-closure of polyhedral CAD-models. The solution accommodates nonmanifold conditions, and guarantees orientable shells. There are several topologically ambiguous situations that might arise during the shell-closure process, and the solution applies intuitively pleasing heuristics in these cases.Mechanical Engineerin

    Workshop on the Integration of Finite Element Modeling with Geometric Modeling

    Get PDF
    The workshop on the Integration of Finite Element Modeling with Geometric Modeling was held on 12 May 1987. It was held to discuss the geometric modeling requirements of the finite element modeling process and to better understand the technical aspects of the integration of these two areas. The 11 papers are presented except for one for which only the abstract is given

    Overview of database projects

    Get PDF
    The use of entity and object oriented data modeling techniques for managing Computer Aided Design (CAD) is explored

    Protease-activated receptor 2 activation induces behavioural changes associated with depression-like behaviour through microglial-independent modulation of inflammatory cytokines

    Get PDF
    Rationale: Major depressive disorder (MDD) is a leading cause of disability worldwide but currently prescribed treatments do not adequately ameliorate the disorder in a significant portion of patients. Hence, a better appreciation of its aetiology may lead to the development of novel therapies. Objectives: In the present study, we have built on our previous findings indicating a role for protease-activated receptor-2 (PAR2) in sickness behaviour to determine whether the PAR2 activator, AC264613, induces behavioural changes similar to those observed in depression-like behaviour. Methods: AC264613-induced behavioural changes were examined using the open field test (OFT), sucrose preference test (SPT), elevated plus maze (EPM), and novel object recognition test (NOR). Whole-cell patch clamping was used to investigate the effects of PAR2 activation in the lateral habenula with peripheral and central cytokine levels determined using ELISA and quantitative PCR. Results: Using a blood–brain barrier (BBB) permeable PAR2 activator, we reveal that AC-264613 (AC) injection leads to reduced locomotor activity and sucrose preference in mice but is without effect in anxiety and memory-related tasks. In addition, we show that AC injection leads to elevated blood sera IL-6 levels and altered cytokine mRNA expression within the brain. However, neither microglia nor peripheral lymphocytes are the source of these altered cytokine profiles. Conclusions: These data reveal that PAR2 activation results in behavioural changes often associated with depression-like behaviour and an inflammatory profile that resembles that seen in patients with MDD and therefore PAR2 may be a target for novel antidepressant therapies
    corecore